Thymalin

Published · Researched 2026-09-21

Overview

Thymalin is a thymus-derived immunomodulator developed by Vladimir Khavinson's group (first obtained 1974, clinically approved in the Soviet Union in the 1980s, still in clinical use in Russia). Critical distinction: pharmaceutical Thymalin® (e.g. Samson-Med, Russia) is a complex of thymic peptides up to 10 kDa extracted from calf thymus — not a single defined molecule. Gray-market Western vendors sell "Thymalin" vials whose listed sequence (Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) is actually thymulin, a defined nonapeptide — a different, single-molecule product trading under the same name. In 2026 Thymalin rides the viral "Russian Epithalon + Thymalin 20-days-once-a-year" protocol across Instagram/Facebook.

Social standing

  • Instagram (primary driver): The Aug 2026 FITSCRIPT reel (880 likes, 780 comments on IG) presenting vials labeled Epithalon and Thymalin as the "2 P3PTIDES" of a "forgotten Russian protocol" — 10 mg daily × 20 days once per year — claiming Russian studies showed users lived longer, got sick less, aged slower. HNR Labs (@hnrlabs, Sept 2026) "FRONTIER" deep-dive carousel on Thymalin as thymus-aging/immunosenescence intervention. Peptide Weekly (Aug 2026) Khavinson retrospective carousel. THE Clinic infographic: "THYMALIN 75MG THYMUS-DERIVED BIOREGULATOR PEPTIDE." Nathan Carvalho (verified X/IG, June 2026) carousel citing a 2022 Russian Advances in Gerontology study: Thymalin lowered COVID-19 hospital mortality to 20.6% vs 28.4% (tocilizumab, ~$5,000) vs 40.9% standard therapy — striking claim, individual study verification UNVERIFIED. A Dec 2025 user reel: household sick for days while he stayed healthy, crediting "thymosin alpha-1 and thymalin for about a month" (personal anecdote, UNVERIFIED). "THYMALIN VS. THYMULIN" explainer graphics circulate, acknowledging the naming confusion.
  • Facebook: The same FITSCRIPT Russian-protocol reel on facebook.com/reel/1361328015687708 drew 1.9K likes / 2.1K comments — the highest-engagement Thymalin post observed.
  • Threads: Thymalin appears in Khavinson-protocol threads; dedicated Thymalin threads are thinner than IG/FB — moderate signal.
  • Recurring praise: the once-yearly 20-day protocol's simplicity vs. 10–12-week peptide clinic cycles; decades of Russian clinical use; pairing with Epithalon.
  • Recurring complaints/failure modes: the Thymalin-vs-thymulin identity confusion (buyers don't know which molecule they're getting); no Western RCTs; dosing inconsistency (pharma IM mg-doses vs. gray-market vial protocols); vendor quality opacity.
  • Representative quotes (attributed): "forgotten Russian protocol" framing — FITSCRIPT presenter, IG/FB reel, Aug 2026; "peptide mix intended to signal the aging thymus back" — HNR Labs carousel, IG, Sept 2026 (paraphrase of slide narrative).

Social validation

Tier 2 — strong independent evidence on Instagram + Facebook (viral reels, educator carousels, high comment counts), moderate on Threads. Named sources: FITSCRIPT Russian-protocol reel (IG reel DcEMqBfo1SD + FB reel 1361328015687708), HNR Labs @hnrlabs (IG), Peptide Weekly (IG), Nathan Carvalho (IG/X), THE Clinic (IG). What each proves: IG/FB prove the Russian-protocol narrative's reach and engagement; HNR/Peptide Weekly prove enthusiast-educator adoption; Carvalho proves the clinical-claim layer (Russian studies) entering Western discourse. Downgraded from Tier 1 because Threads peer-owner discussion is thin and much IG content is educator/vendor-funneled.

Key specs table

Property Value
Identity (pharma) Complex of thymic peptides ≤10 kDa from calf thymus (Thymalin®, Samson-Med) — no single sequence
Identity (gray-market) Usually synthetic thymulin: Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, C33H54N12O15, 858.9 g/mol, CAS 63958-90-7 (vendor-listed; applies to thymulin, NOT to pharma Thymalin complex)
Origin Khavinson group, 1974; Soviet clinical approval 1980s
Mechanism (reported) Restores T/B-lymphocyte number and ratio, stimulates cellular immunity and phagocytosis, supports hematopoiesis and regeneration (Russian clinical literature)
Forms Pharma: 10 mg lyophilized vials (10 vials/pack) for IM injection. Gray market: 10–20 mg lyophilized research vials
Community-reported dosing (OBSERVED, UNVERIFIED) Russian protocol per viral reel: 10 mg/day × 20 days, once yearly (with Epithalon). Pharma label: adults 5–20 mg IM daily × 3–10 days (30–100 mg/course); preventive 5–10 mg × 3–5 days

Pricing

  • Pharma (Russia, Samson-Med 10 mg × 10 vials): sold via Russian pharmacies (e.g. rupharma.com listings); exact 2026 RUB price UNVERIFIED at time of writing.
  • Gray-market street (observed 2026-09-20): Verified Peptides — 10 mg $36.00 (batch-tested Dec 2025, 99.764%); PeptidesWorldWide — 10 mg $49.00; Polaris Peptides ("Thymulin") — 10 mg $40.00; Epitalon + Thymalin bundle (Verified Peptides) — $62.10. Typical US range ~$36–49 per 10 mg vial.
  • Facebook Marketplace: no used Thymalin listings observed — say so plainly (none found).

What's included / what's needed

Vial: lyophilized powder (10 or 20 mg) in sealed 3 mL flip-top vial. Needed: bacteriostatic water or sterile saline for reconstitution, syringes (standard kit). Pharma packs include 10 vials + package insert; diluent (1–2 mL isotonic NaCl) sourced separately per label.

Support reality

Russian pharma Thymalin has normal pharmacy distribution inside Russia; outside Russia buyers rely on gray-market resellers (rupharma-type exporters) with no warranty. Western research vendors publish third-party COAs (purity, endotoxin) — but note the identity problem: a COA for "thymalin" with thymulin's sequence proves you bought thymulin, not the pharma complex. Community rarely discusses this gap; vendor reputation threads focus on delivery/purity, not molecular identity.

Community verdict

Thymalin's 2026 moment is entirely the viral Russian-protocol story — a simple 20-day annual course with a 40-year Russian clinical backstory that Western audiences find compelling. Enthusiasm is real but the evidence most buyers cite is Russian-literature claims, not owned experience, and the thymalin/thymulin identity swap means many buyers aren't getting the molecule in the studies. The honest buyer treats it as an interesting immunosenescence experiment, not an established therapy.

Regulatory & safety status

Thymalin® is an approved drug in Russia (immunodeficiencies, post-chemo immune/hematopoietic depression, chronic infections — per Russian labeling) — it is NOT FDA-approved and has no EMA approval. Gray-market "Thymalin"/"Thymulin" vials are research chemicals not for human use. Safety signals (observed): Russian label lists allergic reactions as the main adverse event; no Western safety database exists for the gray-market product; identity confusion (complex vs. single peptide) is itself a safety-relevant quality risk. Never imply US/EU human-use approval.

Image view breakdown

2/8 views obtained (converted to JPEG 2026-09-20):

  • hero: thymalin-hero.jpg (Peptide Works Thymalin 20 mg vial render — vendor product render, traceable to peptide-works.com)
  • side: thymalin-side.jpg (StrandBio Thymalin 10 mg vial render — traceable to getstrandbio.com) Missing views: rear, top, detail, inuse, scale, box — no real photos found; Russian pharma packaging searches returned irrelevant results.

Not medical advice. This is a research summary of publicly discussed information, not a recommendation to use any substance.

Thymalin — hero view (vendor product render)
hero view — disclosed vendor product render, labeled as such Vendor product render, vendor identified in dossier image log
Thymalin — side view (vendor product render)
side view — disclosed vendor product render, labeled as such Vendor product render, vendor identified in dossier image log

Named sources

  • FITSCRIPT Russian-protocol reel (IG reel DcEMqBfo1SD + FB reel 1361328015687708) — IG/FB prove the Russian-protocol narrative's reach and engagement
  • HNR Labs @hnrlabs (IG) — HNR/Peptide Weekly prove enthusiast-educator adoption
  • Peptide Weekly (IG) — HNR/Peptide Weekly prove enthusiast-educator adoption
  • Nathan Carvalho (IG/X) — Carvalho proves the clinical-claim layer (Russian studies) entering Western discourse.
  • THE Clinic (IG) — IG/FB prove the Russian-protocol narrative's reach and engagement; HNR/Peptide Weekly prove enthusiast-educator adoption; Carvalho proves the clinical-claim layer (Russian studies) entering Western discourse. Downgraded from Tier 1 because Threads peer-owner discussion is thin and much IG content is educator/vendor-funneled.
  • HNR Labs carousel — "forgotten Russian protocol" framing — FITSCRIPT presenter, IG/FB reel, Aug 2026; "peptide mix intended to signal the aging thymus back" — HNR Labs carousel, IG, Sept 2026 (paraphrase of slide narrative). (Aug 2026)
  • Instagram (primary driver) — The Aug 2026 FITSCRIPT reel (880 likes, 780 comments on IG) presenting vials labeled Epithalon and Thymalin as the "2 P3PTIDES" of a "forgotten Russian protocol" — 10 mg daily × 20 days once per year — claiming Russian studies showed users lived longer, got… (Aug 2026)
  • Facebook — The same FITSCRIPT Russian-protocol reel on facebook.com/reel/1361328015687708 drew 1.9K likes / 2.1K comments — the highest-engagement Thymalin post observed.
  • Threads — Thymalin appears in Khavinson-protocol threads; dedicated Thymalin threads are thinner than IG/FB — moderate signal.

Source URLs were not recorded for these references.